|
Seeding of photodynamic
therapy treated vessels
Waterman, Peter 1,2,
Landis, Michael2, Tsai, Sheaumei1,
Kossodo, Sylvie1,2, Nigri, Giuseppe1,2,
Fungaloi, Patrick1,2, Sherwood, Margaret1
and LaMuraglia, Glenn1,2
Wellman Laboratories of Photomedicine1
Massachusetts General Hospital, Division of Vascular Surgery2
Abstract-
There is a clinical need to overcome thrombosis after implantation of
a bypass graft. Endothelial cell seeding is a potential application
to create a non-thrombogenic graft. Photodynamic therapy (PDT) is a
process which creates reactive species that eliminate cells within the
vessel and generate extracellular matrix changes. The aim of this study
was to use PDT to build an ideal natural scaffold seeded with human
endothelial cells (EC), with the ultimate goal of creating a non-thrombogenic
graft. New Zealand white rabbits received the photosensitizer chloroaluminum
sulfonated phthalocyanine (5mg/kg IV) eighteen hours prior to PDT. Twenty-four
hours after the procedure, the treated carotid artery was harvested
and used for seeding. Prior to implantation, some EC were pretreated
with an RGD peptide solution (350 g/ml).
Cells were seeded onto vessels and Dacron graft material. Untreated
and RGD treated cells adhered to both PDT treated vessels and Dacron
graft as shown by propidium iodide staining and confocal microscopy.
The number of adherent cells was comparable on both Dacron and PDT treated
vessel, as measured by MTS assay. Cells pretreated with the RGD peptide
showed a 27% increase adherence thirty minutes following seeding on
both Dacron graft and PDT treated vessels. Cellular function was confirmed
by positive TNF-
induced ELAM expression. This is the first report of EC seeding of PDT
treated vessels, which shows promise as a possible means of creating
an ideal small diameter vascular graft.
Keywords: crosslinked
collagen, endothelial cells, bypass surgery
|